參考文獻(xiàn)/References:
[1] Aaron R K, Gray R L.Osteonecrosis:etiology, natural history, pathophysiology,
and diagnosis[M] // Callaghan J J, Rosenberg A G, Rubash J E.The adult
hip.Philadelphia:Lippincott Williams Wilkins,2007:463-476.
[2] Steinberg D R, Steinberg M E.Osteonecrosis:an overview[J].Techniques in
Orthopaedics, 2008, 23(1):2-10.
[3] 李偉,段曉,范黎,等.葉酸介導(dǎo)的聚乙二醇-聚蘋果酸-喜樹(shù)堿聚合物前藥的制備和性質(zhì)
初探[J].西北藥學(xué)雜志,2013,28(4):396-399.
[4] 郭松巖,崔明鳳,周青,等.PMLA-PEG-TAT納米接枝物的合成和生物活性研究[J].西北藥
學(xué)雜志, 2015,30(2):176-181.
[5] 康爽明,胡海洋,胡嬋娟,等.pH敏感釋藥兩親性殼聚糖共聚物膠束的制備及其性質(zhì)考察
[J].沈陽(yáng)藥科大學(xué)學(xué)報(bào),2011,28(1):6-11.
[6] Han N R, Moon P D, Kim H M, et al.Tryptanthrin ameliorates atopic
dermatitis through down-regulation of TSLP[J].Arch Biochem Biophys,2014(542):14-20.
[7] 吳宗鍵, 王繼芳, 盧世璧, 等.阿侖膦酸鈉對(duì)人成骨細(xì)胞增殖的影響[J].中國(guó)矯形外
科雜志, 2002, 9(5):464-466.